  See all
 |
Articles: Clinical Pharmacology |
Prior Articles
Certolizumab Pegol: In Rheumatoid Arthritis
BioDrugs, 11/10/09
Effect of Transdermal Teriparatide Administration on Bone Mineral Density in Postmenopausal Women
Journal of Clinical Endocrinology and Metabolism, 11/10/09 Celecoxib in arthritis: relative risk management profile and implications for patients
Therapeutics and Clinical Risk Management, 11/10/09
Free full text
Infliximab therapy in pediatric Takayasus arteritis: report of two cases
Rheumatology International, 11/10/09 Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: Clinicopathological features of 24 patients
Journal of Rheumatology, 11/09/09 Serum homocysteine, folate and vitamin B12 in patients with Paget's disease of bone: the effect of zoledronic acid
Journal of Bone and Mineral Metabolism, 11/09/09
Exclusive Author Commentary Infusion of ibandronate once every 3 months effectively decreases bone resorption markers and increases bone mineral density in Chinese postmenopausal osteoporotic women: a 1-year study
Journal of Bone and Mineral Metabolism, 11/09/09 Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögrens syndrome
Arthritis & Rheumatism, 11/06/09 Epitope-specific immunotherapy of rheumatoid arthritis: Clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial
Arthritis & Rheumatism, 11/06/09 Viscosupplementation Treatment of Arthritis Pain
Current Pain and Headache Reports, 11/06/09 Update on the Management of Pain in Arthritis and the Use of Cyclooxygenase-2 Inhibitors
Current Pain and Headache Reports, 11/06/09 Progressive multifocal leukoencephalopathy following rituximab treatment in a patient with rheumatoid arthritis
Arthritis & Rheumatism, 11/06/09 Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor [alpha] therapies: Does the risk change with the time since start of treatment?
Arthritis & Rheumatism, 11/05/09 Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Kidney International, 11/05/09 The relationship between synovial lymphocyte aggregates and the clinical response to infliximab in rheumatoid arthritis: A prospective study
Arthritis & Rheumatism, 11/04/09 Incidence and predictors of osteonecrosis among cyclosporin- or tacrolimus-treated renal allograft recipients
Rheumatology International, 11/04/09 Treatment of early RA with infliximab is beneficial
American Pharmacists Association, 11/04/09
Free full text
Improved influenza and pneumococcal vaccination in rheumatology patients taking immunosuppressants using an electronic health record best practice alert
Arthritis Care and Research, 11/03/09 Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial
Arthritis & Rheumatism, 11/03/09 Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic Agents. A Cost-Effectiveness Analysis
Annals of Internal Medicine, 11/03/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatology
more...
|
250 Available Pages
|
|
